Bhatia R Sacha, Tu Jack V, Lee Douglas S, Austin Peter C, Fang Jiming, Haouzi Annick, Gong Yanyan, Liu Peter P
Heart & Stroke/Richard Lewar Centre of Excellence, University of Toronto, and the Division of Cardiology, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
N Engl J Med. 2006 Jul 20;355(3):260-9. doi: 10.1056/NEJMoa051530.
The importance of heart failure with preserved ejection fraction is increasingly recognized. We conducted a study to evaluate the epidemiologic features and outcomes of patients with heart failure with preserved ejection fraction and to compare the findings with those from patients who had heart failure with reduced ejection fraction.
From April 1, 1999, through March 31, 2001, we studied 2802 patients admitted to 103 hospitals in the province of Ontario, Canada, with a discharge diagnosis of heart failure whose ejection fraction had also been assessed. The patients were categorized in three groups: those with an ejection fraction of less than 40 percent (heart failure with reduced ejection fraction), those with an ejection fraction of 40 to 50 percent (heart failure with borderline ejection fraction), and those with an ejection fraction of more than 50 percent (heart failure with preserved ejection fraction). Two groups were studied in detail: those with an ejection fraction of less than 40 percent and those with an ejection fraction of more than 50 percent. The main outcome measures were death within one year and readmission to the hospital for heart failure.
Thirty-one percent of the patients had an ejection fraction of more than 50 percent. Patients with heart failure with preserved ejection fraction were more likely to be older and female and to have a history of hypertension and atrial fibrillation. The presenting history and clinical examination findings were similar for the two groups. The unadjusted mortality rates for patients with an ejection fraction of more than 50 percent were not significantly different from those for patients with an ejection fraction of less than 40 percent at 30 days (5 percent vs. 7 percent, P=0.08) and at 1 year (22 percent vs. 26 percent, P=0.07); the adjusted one-year mortality rates were also not significantly different in the two groups (hazard ratio, 1.13; 95 percent confidence interval, 0.94 to 1.36; P=0.18). The rates of readmission for heart failure and of in-hospital complications did not differ between the two groups.
Among patients presenting with new-onset heart failure, a substantial proportion had an ejection fraction of more than 50 percent. The survival of patients with heart failure with preserved ejection fraction was similar to that of patients with reduced ejection fraction.
射血分数保留的心力衰竭的重要性日益受到认可。我们开展了一项研究,以评估射血分数保留的心力衰竭患者的流行病学特征和转归,并将研究结果与射血分数降低的心力衰竭患者进行比较。
从1999年4月1日至2001年3月31日,我们对加拿大安大略省103家医院收治的2802例出院诊断为心力衰竭且已评估射血分数的患者进行了研究。患者被分为三组:射血分数低于40%的患者(射血分数降低的心力衰竭)、射血分数为40%至50%的患者(射血分数临界的心力衰竭)以及射血分数高于50%的患者(射血分数保留的心力衰竭)。对两组进行了详细研究:射血分数低于40%的患者和射血分数高于50%的患者。主要结局指标为1年内死亡和因心力衰竭再次入院。
31%的患者射血分数高于50%。射血分数保留的心力衰竭患者更可能为老年女性,且有高血压和心房颤动病史。两组的现病史和临床检查结果相似。射血分数高于50%的患者在30天时(5%对7%,P=0.08)和1年时(22%对26%,P=0.07)的未调整死亡率与射血分数低于40%的患者无显著差异;两组的调整后1年死亡率也无显著差异(风险比,1.13;95%置信区间,0.94至1.36;P=0.18)。两组因心力衰竭再次入院率和住院并发症发生率无差异。
在新发心力衰竭患者中,相当一部分患者射血分数高于50%。射血分数保留的心力衰竭患者的生存率与射血分数降低的心力衰竭患者相似。